TRM: A Powerful Two‐Stage Machine Learning Approach for Identifying SNP‐SNP Interactions
Hui‐Yi Lin(Moffitt Cancer Center), Jong Y. Park(Moffitt Cancer Center), Y. Ann Chen(Zhejiang Chinese Medical University), Tung‐Sung Tseng(Louisiana State University Health Sciences Center New Orleans), Ya‐Yu Tsai(Moffitt Cancer Center), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 30
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
|Journal of Clinical Oncology|2013|530